Ifp-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-05
Total Holdings
4,312
Total Value
3243123494
Accession Number
0001641866-25-000006
Form Type
13F-HR
Manager Name
Ifp-Advisors
Data Enrichment
67% identified
2,910 identified1,402 unidentified

Holdings

4,312 positions • $3.2B total value
Manager:
Search and click to pin securities to the top
Page 216 of 216
CODEXIS, INC.
Shares:1
Value:$3
% of Portfolio:0.0% ($3/$3.2B)
biote Corp.
Shares:1
Value:$3
% of Portfolio:0.0% ($3/$3.2B)
AgEagle Aerial Systems Inc.
Shares:2
Value:$3
% of Portfolio:0.0% ($3/$3.2B)
Ovid Therapeutics Inc.
Shares:8
Value:$2
% of Portfolio:0.0% ($2/$3.2B)
73730P108
Shares:0
Value:$2
% of Portfolio:0.0% ($2/$3.2B)
Akoya Biosciences, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$3.2B)
Werewolf Therapeutics, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$3.2B)
Lineage Cell Therapeutics, Inc.
Shares:3
Value:$1
% of Portfolio:0.0% ($1/$3.2B)
PharmaCyte Biotech, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$3.2B)
22nd Century Group, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$3.2B)
MACROGENICS INC
Shares:0
Value:$1
% of Portfolio:0.0% ($1/$3.2B)
Inozyme Pharma, Inc.
Shares:1
Value:$1
% of Portfolio:0.0% ($1/$3.2B)